Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

An Exploratory Study on Pseudo-Data Generation in Prescription and Adverse Drug Reaction Extraction.

Tao C, Lee K, Filannino M, Uzuner Ö.

Stud Health Technol Inform. 2019 Aug 21;264:388-392. doi: 10.3233/SHTI190249.

PMID:
31437951
2.

The protective effect of resveratrol against risperidone-induced liver damage through an action on FAS gene expression.

Azirak S, Bilgic S, Tastemir Korkmaz D, Guvenc AN, Kocaman N, Ozer MK.

Gen Physiol Biophys. 2019 May;38(3):215-225. doi: 10.4149/gpb_2018045.

PMID:
31184308
3.

Can screening tools for potentially inappropriate prescriptions in older adults prevent serious adverse drug events?

Wang-Hansen MS, Wyller TB, Hvidsten LT, Kersten H.

Eur J Clin Pharmacol. 2019 May;75(5):627-637. doi: 10.1007/s00228-019-02624-1. Epub 2019 Jan 20.

PMID:
30662995
4.

[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)].

Hüppe D, Serfert Y, Buggisch P, Mauss S, Böker KHW, Müller T, Klinker H, Günther R, Berg T, Cornberg M, Niederau C, Sarrazin C, Simon KG, Zeuzem S, Manns MP, Wedemeyer H.

Z Gastroenterol. 2019 Jan;57(1):27-36. doi: 10.1055/a-0821-7188. Epub 2019 Jan 14. German.

PMID:
30641600
5.

Pharmacogenetic content of commercial genome-wide genotyping arrays.

Lemieux Perreault LP, Zaïd N, Cameron M, Mongrain I, Dubé MP.

Pharmacogenomics. 2018 Oct;19(15):1159-1167. doi: 10.2217/pgs-2017-0129. Epub 2018 Oct 1.

PMID:
30272537
6.

Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities - Polish Adult Leukemia Group (PALG) real-life analysis.

Długosz-Danecka M, Jurczak W, Łątka-Cabała E, Morawska M, Gawroński K, Wiśniewska A, Dudziński M, Wąsik-Szczepanek E, Chmielowska E, Łabędź A, Wdowiak K, Hus I.

Pol Arch Intern Med. 2018 Aug 31;128(7-8):421-426. doi: 10.20452/pamw.4294. Epub 2018 Jul 11.

7.

Gena Norris and gadolinium deposition disease-the impact of celebrity health disclosure on public awareness.

McNamara C, Rahmani G.

Magn Reson Med. 2018 Oct;80(4):1277-1278. doi: 10.1002/mrm.27223. Epub 2018 May 10. No abstract available.

PMID:
29749076
8.

A Systems Approach to Identify Factors Influencing Adverse Drug Events in Nursing Homes.

Al-Jumaili AA, Doucette WR.

J Am Geriatr Soc. 2018 Jul;66(7):1420-1427. doi: 10.1111/jgs.15389. Epub 2018 Apr 24.

PMID:
29691843
9.

Electronic Medication Administration Records in Long-Term Care Facilities: A Scoping Review.

Fuller AEC, Guirguis LM, Sadowski CA, Makowsky MJ.

J Am Geriatr Soc. 2018 Jul;66(7):1428-1436. doi: 10.1111/jgs.15384. Epub 2018 Apr 23. Review.

PMID:
29684250
10.

Reducing harm to patients caused by avoidable adverse drug reactions.

Glasper A.

Br J Nurs. 2018 Apr 26;27(8):456-457. doi: 10.12968/bjon.2018.27.8.456.

PMID:
29683749
11.

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.

Haratani K, Hayashi H, Chiba Y, Kudo K, Yonesaka K, Kato R, Kaneda H, Hasegawa Y, Tanaka K, Takeda M, Nakagawa K.

JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925.

Supplemental Content

Loading ...
Support Center